Immunohaematological Testing, Monitoring, and Treatment of Haemolytic Disease of the Newborn: Where are we in this Field after 25 Years?
References
- de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth. 2023;23:12.
- Raguz MJ, Prce Z, Bjelanovic V, Bjelanovic I, Dzida S, Mabic M. 20 years of follow-up alloimmunization and hemolytic disease in newborn: Has anything changed in the field over the years? Klin Paediatr. 2020;232:314–20.
- Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: Modern practice and future investigations. Transfus Med Rev. 2016;16:3011–6.
- Myle AK, Al-Khattabi GH. Hemolytic disease of the newborn: A review of current trends and prospects. Pediatr Health Med Ther. 2021;12:491–498
- Watchko JF. Neonatal indirect hyperbilirubinemia and kernicterus. In: Christine A. Gleason and Sandra E. Juul, editors, Avery’s Diseases of the Newborn. Elsevier; 2018:1198–1218.
- Smith HM, Shirey RS, Thoman SK, et al. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology 2013;4:127–30.
- Basu S, Kaur R, Kaur G. Hemolytic disease ofthe fetus and newborn: Current trends and perspectives. Asian J Transfus Sci. 2011;5:3–7.
- Murray NA, Roberts I. Haemolytic disease of the newborn. ADC Fetal Neonatal Ed. 2007;92:83–88.
- Hall V, Vadakekut ES, Maines J, Avulakunta ID. Hemolytic disease of the fetus and newborn. National Library of Medicine. 2025:
https://www.ncbi.nlm.nih.gov/books/NBK557423/#_ncbi_dlg_citbx_NBK557423 . - American Academy of Pediatrics. Management of hiperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatr. 2004;114:1138.
- Júnior MDC, Sosa SEY, Fernandes M, do Carmo L, de Oliveira RW, Kanevsky G. Hemolytic disease ofthe fetus and newborn and Rhesus alloimmunization in Latin American countries: A scoping review. BMC Pregnancy Childbirth. 2024 Dec 20;24(1):830. doi: 10.1186/s12884-024-07044-3.
- Kureba AA, Gudu W, Mersha A, Jemal E, Abdosh AA. Perinatal outcome of pregnant women with RHD sensitization: A five-year cross-sectional study at a tertiary care hospital in Ethiopia. Int J Womens Health. 2023;15:571–578.
- Kristinsdottir T, Kjartansson S, Hardardottir H, et al. Positive Coomb’s test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012. Laeknabladid 2016;102:326–31.
- de Winter DP, Hulzebos C, Van ‘t Oever RM, De Haas M, Verweij EJ, Lopriore E. History and current standard of postnatal management in hemolytic disease of the fetus and newborn. Eur J Pediatr. 2023;182:489–500.
- Watchko JF. ABO hemolytic disease of the newborn: A need for clarity and consistency in diagnosis. J Perinatol. 2023 Feb;43(2):242–247.
- Rodrigues MMO, Mattos D, Almeida S, Fiegenbaum M. Hemolytic disease of the fetus and newborn—a perspective of immunohematology. Hematol Transfus Cell Ther. 2024;5:246–S257.
DOI: https://doi.org/10.34763/jmotherandchild.20263001.d-26-00007 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 161 - 166
Submitted on: Jan 27, 2026
Accepted on: Apr 30, 2026
Published on: Sep 25, 2026
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
Related subjects:
© 2026 Marjana Jerković Raguž, Sanja Klarić, Mirela Mabić, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.